论文部分内容阅读
恶性淋巴瘤对放化疗敏感,常规治疗可使60%的霍奇金病(HD)和30%～50%的非霍奇金淋巴瘤(NHL)患者得到治愈或长期无病生存,但对具有不良预后因素的难治性、复发性淋巴瘤疗效则较差。我院采用高剂量化疗联合自体外周血造血干细胞移植(APBSCT)治疗10例难治性、复发性恶性淋巴瘤患者?
Malignant lymphomas are sensitive to radiotherapy and chemotherapy. Conventional treatment results in 60% of Hodgkin’s disease (HD) and 30% to 50% of non-Hodgkin’s lymphoma (NHL) patients who are cured or have long-term disease-free survival, Poor prognosis of refractory factors, the efficacy of recurrent lymphoma is poor. High-dose chemotherapy in our hospital combined with autologous peripheral blood stem cell transplantation (APBSCT) treatment of 10 patients with refractory, recurrent malignant lymphoma?